Filing Flows › CorMedix (CRMD) › Operating margin
CorMedix (CRMD) operating margin by quarter
CorMedix's operating margin was 42.1% in Q2 2026 (second quarter 2026), -7.9 pts from Q1 2026. Over the last 7 quarters it ranged from 41.4% (Q4 2024) to 51.5% (Q1 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 42.1% | -7.9 pts | -7.1 pts |
| Q1 2026 | 50.0% | +4.0 pts | -1.5 pts |
| Q4 2025 | 46.0% | -3.3 pts | +4.5 pts |
| Q3 2025 | 49.2% | +0.1 pts | — |
| Q2 2025 | 49.2% | -2.3 pts | — |
| Q1 2025 | 51.5% | +10.0 pts | — |
| Q4 2024 | 41.4% | — | — |
Q2 2026 at a glance
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is CorMedix's operating margin?
CorMedix's operating margin was 42.1% in Q2 2026 (second quarter 2026), -7.9 pts from Q1 2026.
How has CorMedix's operating margin changed?
Over the last 7 quarters it ranged from 41.4% (Q4 2024) to 51.5% (Q1 2025).